Retatrutide has emerged as a new treatment in the fight against obesity. This revolutionary drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By activating these receptors, Retatrutide suppresses appetite, {promotesinsulin secretion, and ultimately leads to significant slimming. While research